Ashish Mandelia, VP, Chief Accounting Officer: Mersana Therapeutics MRSN Sell · Filed 24/01/17

Trade details

Type: Insider sale
Amount: $13,617.75
Shares · price: 5,025 sh · $2.71 a share
Held after: 23,328 sh
Stock: Mersana Therapeutics MRSN
Person: Ashish MandeliaVP, Chief Accounting Officer
Trade date: 24/01/16
Filed: 24/01/17
Days to filing: 1 days

Sold 17.7% of holdings

Share of holding sold: 17.7%

Mersana Therapeutics trades, last 26 weeks

What else happened in Mersana Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/17~24/02/15

Ashish Mandelia's recent trades

Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$2,061
3,554 sh
$2,061
Filed 25/01/17
Traded 25/01/16
Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$1,128
1,791 sh
$1,128
Filed 25/01/16
Traded 25/01/15
Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$665
1,007 sh
$665
Filed 25/01/15
Traded 25/01/14
Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$9,710
4,855 sh
$9,710
Filed 24/10/07
Traded 24/10/02
Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$6,588
3,361 sh
$6,588
Filed 24/10/07
Traded 24/10/03